Antimicrobial 2-deoxystreptamine compounds

Details for Australian Patent Application No. 2005304713 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Migawa, Michael T.; Hanessian, Stephen; Swayze, Eric E.; Griffey, Richard H.; Adhikari, Susanta Sekhar; Pachamuthu, Kandasamy; Szychowski, Janek

Agent Davies Collison Cave

Pub. Number AU-B-2005304713

PCT Pub. Number WO2006/052930

Priority 60/625,440 05.11.04 US

Filing date 7 November 2005

Wipo publication date 18 May 2006

Acceptance publication date 22 December 2011

International Classifications

C07H 15/232 (2006.01) Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

A61K 31/70 (2006.01) - Carbohydrates

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/052930 Priority application(s): WO2006/052930

22 December 2011 Application Accepted

  Published as AU-B-2005304713

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005304715-Method and apparatus for deriving transmission timing of a downlink control channel in support of enhanced uplink operation

2005304710-Bioptome